Abstract
The high incidence of community-acquired pneumonia against the backdrop of continued registration of COVID-19 requires early differential diagnosis, due to different patient management tactics. Among community-acquired pneumonias, legionella diseases deserve special attention. The difficulty of clinical diagnosis of legionellosis during the COVID-19 pandemic leads to untimely prescription of specific antibacterial therapy, which worsens the prognosis of the outcome of the disease. The work provides clinical examples that draw the attention of specialists to the features of clinical, laboratory and radiological manifestations of legionellosis, as well as the important role of epidemiological data for the differential diagnosis of legionellosis from the new coronavirus infection COVID-19.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
